Adolescents with type 2 diabetes benefit from dulaglutide

被引：0
|
作者：
Krome, Susanne
机构：
来源：
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT | 2022年 / 147卷 / 22期
关键词：
D O I：
10.1055/a-1924-9962
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1430 / 1430
页数：1
相关论文
共 50 条
  • [21] Pharmacokinetics of Once Weekly Dulaglutide in Patients with Type 2 Diabetes Mellitus
    De la Pena, Amparo
    Loghin, Corina
    Cui, Xuewei
    Zhang, Xin
    Geiser, Jeanne S.
    Martin, Jennifer A.
    Chien, Jenny Y.
    DIABETES, 2014, 63 : A251 - A252
  • [22] REAL WORLD EFFECTIVENESS OF DULAGLUTIDE AMONG PATIENTS WITH TYPE 2 DIABETES
    Mody, R.
    Yu, M.
    Fernandez, L.
    Shui, A.
    Kallenbach, L.
    Slipski, L.
    de Oliveira, Piras C.
    VALUE IN HEALTH, 2017, 20 (05) : A164 - A164
  • [23] Clinical efficacy and predictors of response to dulaglutide in type-2 diabetes
    Berra, C. C.
    Resi, V
    Mirani, M.
    Folini, L.
    Rossi, A.
    Solerte, S. B.
    Fiorina, P.
    PHARMACOLOGICAL RESEARCH, 2020, 159
  • [24] Once-Weekly Dulaglutide for the Treatment of Youths with Type 2 Diabetes
    Arslanian, Silva A.
    Hannon, Tamara
    Zeitler, Philip
    Chao, Lily C.
    Boucher-Berry, Claudia
    Barrientos-Perez, Margarita
    Bismuth, Elise
    Dib, Sergio
    Cho, Jang Ik
    Cox, David
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 387 (05): : 433 - 443
  • [25] Once-Weekly Dulaglutide for Treatment of Youths with Type 2 Diabetes
    Senoo, Yuki
    Kami, Masahiro
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 387 (16): : 1529 - 1530
  • [26] β-Cell Function and Glycemic Response to Dulaglutide in Patients with Type 2 Diabetes
    Hasebe, Masashi
    Yoshiji, Satoshi
    Iwasaki, Yorihiro
    Kimura, Sadahito
    Seno, Yohei
    Keidai, Yamato
    Haraguchi, Takuya
    Iwasaki, Kanako
    Wada, Yoshiharu
    Honjo, Sachiko
    Fujikawa, Jun
    Hamasaki, Akihiro
    DIABETES, 2021, 70
  • [27] Impact of Early Initiation of Dulaglutide on MC in Patients with Type 2 Diabetes
    Hoog, Meredith
    Smith, Joseph L.
    Yu, Maria
    Peleshok, Jennifer
    Mody, Reema
    Grabner, Michael
    DIABETES, 2021, 70
  • [28] Pharmacokinetics of once weekly dulaglutide in patients with type 2 diabetes mellitus
    de la Pena, A.
    Loghin, C.
    Cui, X.
    Zhang, X.
    Geiser, J. S.
    Martin, J.
    Chien, J. Y.
    DIABETOLOGIA, 2014, 57 : S349 - S349
  • [29] Improving glycemic control: transitioning from dulaglutide to tirzepatide in patients with type 2 diabetes undergoing hemodialysis
    Otsuka, Emiko
    Kitamura, Mineaki
    Funakoshi, Satoshi
    Mukae, Hiroshi
    Nishino, Tomoya
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [30] Effects of switching from liraglutide to semaglutide or dulaglutide in patients with type 2 diabetes: A randomized controlled trial
    Iijima, Takahiro
    Makoto, Shibuya
    Ito, Yuzuru
    Terauchi, Yasuo
    JOURNAL OF DIABETES INVESTIGATION, 2023, 14 (06) : 774 - 781
12345